COVID-19 Related Coagulopathy: A Distinct Entity?

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.

Keywords

• coronavirus disease 2019
• COVID-19
• thrombosis
• hemostasis
• microparticles
• endothelium